Reduced-dose direct oral anticoagulants (DOACs) in the extended treatment of venous thromboembolism: A systematic review and meta-analysis-Response to Commentary

J Thromb Haemost. 2021 Sep;19(9):2359-2360. doi: 10.1111/jth.15427.

Authors

Lakshman Vasanthamohan¹, Kochawan Boonyawat², Chatree Chai-Adisaksopha³, Mark Crowther⁴

Affiliations

¹ Division of Hematology, Department of Medical Oncology, Lakeridge Health, Oshawa, Ontario, Canada.
² Division of Hematology, Department of Medicine, Mahidol University, Bangkok, Thailand.
³ Division of Hematology, Department of Internal Medicine, Chiang Mai University, Chiang Mai, Thailand.
⁴ Division of Hematology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

PMID: 34435431
DOI: 10.1111/jth.15427

No abstract available

Keywords: DOAC; anticoagulation; meta-analysis; systematic review; thrombosis.

Publication types

Letter
Meta-Analysis
Systematic Review

MeSH terms

Administration, Oral
Anticoagulants
Hemorrhage / chemically induced
Hemorrhage / drug therapy
Humans
Venous Thromboembolism* / drug therapy

Substances

Anticoagulants